Korean J Gastroenterol.  2017 Jul;70(1):27-32. 10.4166/kjg.2017.70.1.27.

The Effect of Helicobacter pylori Eradication on the Metachronous Neoplasm after Endoscopic Resection for Gastric Dysplasia

Affiliations
  • 1Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea. syyang@snuh.org
  • 2Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND/AIMS
Helicobacter pylori (Hp) infection is an important risk factor for gastric carcinogenesis. Although several studies have investigated the effect of Hp eradication on the development of metachronous neoplasm after endoscopic resection of the gastric dysplasia, the evidence is still insufficient to make a clear conclusion. The aims of this study was to evaluate the risk factors for the development of metachronous neoplasm after endoscopic resection of gastric dysplasia and to investigate the effect of Hp eradication.
METHODS
Between 2005 and 2011, a total of 887 patients underwent endoscopic resection for gastric dysplasia. Among them, 521 patients who had undergone tests for Hp infection and been followed-up for at least one year were included in the final analyses. Of the 292 Hp-positive patients, 116 patients were successfully eradicated, while 176 failed or did not undergo eradication.
RESULTS
During a mean follow-up of 59.1 months (range 12-125 months), metachronous neoplasm had developed in 63 patients (12.1%, dysplasia in 38, carcinoma in 25). In multivariate analyses, age ≥65 (hazard ratio [HR]=2.247, 95% confidence interval [CI] 1.297-3.895), tumor size (HR=1.283, 95% CI 1.038-1.585), synchronous lesion (HR=2.341, 95% CI 1.244-4.405), family history of gastric cancer (HR=3.240, 95% CI 1.776-5.912), and smoking (HR=1.016, 95% CI 1.003-1.029) were risk factors for metachronous neoplasm after endoscopic resection of gastric dysplasia. However, Hp eradication was not associated with metachronous neoplasm (HR=0.641, 95% CI 0.297-1.384).
CONCLUSIONS
Hp eradication was not shown to be associated with the development of metachronous cancer after endoscopic resection of gastric dysplasia.

Keyword

Helicobacter pylori; Metachronous neoplasm; Precancerous condition; Endoscopic mucosal resection

MeSH Terms

Carcinogenesis
Follow-Up Studies
Helicobacter pylori*
Helicobacter*
Humans
Multivariate Analysis
Neoplasms, Second Primary*
Precancerous Conditions
Risk Factors
Smoke
Smoking
Stomach Neoplasms
Smoke

Figure

  • Fig. 1. Cumulative incidence rate of metachronous tumor (Kaplan-Meier survival curve). There was no significant difference of cumulative incidence rate of metachronous tumor in accordance with the status of Helicobacter pylori (Hp) infection.


Reference

References

1. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988; 48:3554–3560.
2. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004; 291:187–194.
3. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology. 2009; 137:1641–1648. e1-e2.
Article
4. Chen HN, Wang Z, Li X, Zhou ZG. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a metaanalysis. Gastric Cancer. 2016; 19:166–175.
Article
5. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008; 372:392–397.
Article
6. Choi J, Kim SG, Yoon H, et al. Eradication of helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol. 2014; 12:793–800.e1.
7. Maehata Y, Nakamura S, Fujisawa K, et al. Longterm effect of helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc. 2012; 75:39–46.
Article
8. Kato M, Nishida T, Yamamoto K, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut. 2013; 62:1425–1432.
Article
9. Chon I, Choi C, Shin CM, Park YS, Kim N, Lee DH. Effect of helicobacter pylori eradication on subsequent dysplasia development after endoscopic resection of gastric dysplasia. Korean J Gastroenterol. 2013; 61:307–312.
10. Shin SH, Jung DH, Kim JH, et al. Helicobacter pylori eradication prevents metachronous gastric neoplasms after endoscopic resection of gastric dysplasia. PLoS One. 2015; 10:e0143257. eCollection 2015.
Article
11. Rugge M, Di Mario F, Cassaro M, et al. Pathology of the gastric antrum and body associated with helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology. 1993; 22:9–15.
Article
12. Kobayashi M, Hashimoto S, Mizuno K, et al. Therapeutic or spontaneous helicobacter pylori eradication can obscure magnifying narrow-band imaging of gastric tumors. Endosc Int Open. 2016; 4:E665–E672.
Article
13. Kawanaka M, Watari J, Kamiya N, et al. Effects of helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial. Br J Cancer. 2016; 114:21–29.
Article
14. Niwa T, Tsukamoto T, Toyoda T, et al. Inflammatory processes triggered by helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010; 70:1430–1440.
Article
15. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007; 128:683–692.
Article
16. Mori G, Nakajima T, Asada K, et al. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful helicobacter pylori eradication: results of a largescale, multicenter cohort study in Japan. Gastric Cancer. 2016; 19:911–918.
Article
17. Nakajima T, Maekita T, Oda I, et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev. 2006; 15:2317–2321.
Article
18. Bae SE, Jung HY, Kang J, et al. Effect of helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm. Am J Gastroenterol. 2014; 109:60–67.
Article
19. Yoon SB, Park JM, Lim CH, et al. Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc. 2016; 83:1176–1183.
Article
20. Cho CJ, Ahn JY, Jung HY, et al. The incidence and locational predi-lection of metachronous tumors after endoscopic resection of high-grade dysplasia and early gastric cancer. Surg Endosc. 2017; 31:389–397.
Article
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr